BSE filing, NSE: METROPOLIS. Summary written from the filing by ALFA Finder's alert engine.
Metropolis Healthcare Ltd: key numbers
- Share price
- ₹547.00
- Market cap
- ₹11,348 Cr
- Revenue (annual)
- ₹1,646 Cr
- Net profit (annual)
- ₹190.0 Cr
- P/E (TTM)
- 56.3×Sector 51.1×
- Promoter holding
- 47.82%-1.04% QoQ
- FII holding
- 11.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Metropolis Healthcare Ltd
All →Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Metropolis Healthcare Other Announcement
Metropolis Healthcare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure provides details on the company's equity share distribution.
Metropolis Healthcare Employee Stock Options
Metropolis Healthcare allotted 9,516 equity shares under its RSU Plan, 2020. This issuance follows the exercise of vested stock units by employees.
Metropolis Healthcare Other Announcement
Metropolis Healthcare filed the quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Metropolis Healthcare Business Update
Metropolis Healthcare provided a business update for Q2FY27, reporting 15% Y-o-Y revenue growth driven by increased patient and test volumes alongside improved EBITDA margins.
Metropolis Healthcare Employee Stock Options
Metropolis Healthcare allotted 66,312 equity shares to employees under its RSU Plan, 2020. This exercise follows the vesting of RSUs previously granted to staff.
Other capital structure change announcements
All →Meesho Capital Structure Change
Meesho approved up to Rs.400 Crore capital infusion into its wholly owned subsidiary, Meesho Payments. Board also approved a new subsidiary and further Kirana Club investments.
- Value
- ₹400.0 Cr
Womancart Capital Structure Change
Womancart Limited submitted its draft letter of offer for a rights issue of up to Rs.1,200 lakhs to eligible shareholders. The issue is pending in-principle approval from NSE Emerge, with the price, ratio and dates still blank.
- Value
- ₹12.00 Cr
Hero MotoCorp Capital Structure Change
Hero MotoCorp's board approved up to ₹300 Crore additional investment in wholly-owned subsidiary HMCL Netherlands B.V., in tranches over two years. Quarterly results were also approved.
- Value
- ₹300.0 Cr
- Execution
- 2 years, in one or more tranches
Great Eastern Shipping Company Capital Structure Change
Great Eastern Shipping bought back 88,877 equity shares on 28 October 2026 at an average of Rs.1,529.71. Total shares bought back under the open-market buyback now stand at 38,48,494.
- Value
- ₹13.60 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme bought back 64,583 shares on 28-10-2026 at an average ₹262.49, totalling 23,56,451 shares to date. Purchases were made via Emkay Global on the open market.
- Value
- ₹1.70 Cr
Blue Chip Tex Industries Capital Structure Change
Counter Cyclical Investments PMS sold 2,986 shares (0.15%) of Blue Chip Tex via open market, reducing its stake from 5.62% to 5.46%. The filing is a non-promoter SAST Reg 29(2) disclosure.